Related Experiment Video
Updated: Feb 27, 2026
07:15
An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
3.1K
[News about pericardial diseases in 2016]
Baris Karpuz1, Valèrie Duchatelle1, Maxime Tapponnier1
1Service de cardiologie, Hôpital du Valais, Centre hospitalier du centre du Valais, Hôpital de Sion, Avenue du Grand-Champsec 80, 1950 Sion.
Revue Medicale Suisse
|July 5, 2017
Summary
The 2015 European Society of Cardiology guidelines update pericarditis management, recommending colchicine with NSAIDs for initial treatment and routine heart ultrasounds for pericardial diseases.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Guidelines
Background:
- The European Society of Cardiology (ESC) published updated guidelines in 2015 for managing pericardial diseases.
- These guidelines incorporate expert opinions and findings from recent clinical studies.
Purpose of the Study:
- To provide updated recommendations for the management of pericardial diseases.
- To refine criteria for hospitalization and define severe cases.
- To outline current therapeutic strategies, including pharmacotherapy and diagnostic imaging.
Main Methods:
- Review of existing clinical studies and expert consensus.
- Development of evidence-based recommendations for diagnosis and treatment.
- Emphasis on updated pharmacological approaches and diagnostic imaging.
Main Results:
- Revised criteria for hospitalization and definition of severe pericardial disease cases.
- Introduction of colchicine as a first-line therapy in combination with non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin for pericarditis.
- Recommended a 3-month duration for this initial bi-therapy.
- Systematic performance of echocardiography (heart ultrasound) for all pericardial diseases.
- Recommendation to restrict physical activity, particularly in cases of perimyocarditis.
Conclusions:
- The updated guidelines offer a refined approach to managing pericardial diseases.
- Colchicine combined with NSAIDs/aspirin is now the recommended initial treatment for pericarditis.
- Echocardiography and activity modification are crucial components of management.
More Related Videos
Related Concept Videos
01:22Pericarditis I: Introduction
506
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
506
01:19Pericarditis II: Clinical Features and Diagnostic Tests
424
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
424
01:17Pericarditis III: Medical Management
432
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
432
01:25Pericarditis IV: Nursing Management
469
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
469
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
565
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
01:27Myocarditis II: Clinical Features and Diagnostic Tests
385
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
385